FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 361:1597-1598 October 15, 2009 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Kurella Tamura, M. PubMed Citation

The methods and availability of dialysis and transplantation have improved, and patients who are beginning to undergo dialysis have become sicker and more debilitated than in the past.¹ Increased numbers of elderly, ill patients with end-stage renal disease (ESRD) increase the costs of ESRD programs, despite an overall decrease in the cost of dialysis for each patient.¹

Although dialysis can prolong life, the benefit to individual patients varies widely. Randomized trials are lacking to evaluate the benefits of dialysis in the elderly. A nonrandomized study suggests that dialysis, as compared with conservative therapy, increases longevity in elders, but not in . . . [Full Text of this Article]

Source Information

From the Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh (R.M.A.); and the Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston (M.L.Z.).

This article has been cited by other articles:

• (2009). Dialysis in Elders. JWatch General 2009: 2-2 [Full Text]